Agilon HealthAGL
AGL
About: Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Employees: 1,117
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 9 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
20% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $10.2M
18% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 39
3% more funds holding
Funds holding: 203 [Q2] → 210 (+7) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]
2% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 63
20.49% less ownership
Funds ownership: 124.53% [Q2] → 104.04% (-20.49%) [Q3]
50% less capital invested
Capital invested by funds: $3.35B [Q2] → $1.68B (-$1.67B) [Q3]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$1.75
11%
downside
Avg. target
$2.58
31%
upside
High target
$4
103%
upside
9 analyst ratings
1 positive
11%
5 neutral
56%
3 negative
33%
Macquarie Tao Qiu 33% 1-year accuracy 5 / 15 met price target | 52%upside $3 | Neutral Initiated | 16 Dec 2024 |
Bernstein Lance Wilkes 0% 1-year accuracy 0 / 3 met price target | 27%upside $2.50 | Market Perform Initiated | 11 Dec 2024 |
RBC Capital Sean Dodge 50% 1-year accuracy 21 / 42 met price target | 52%upside $3 | Outperform Reiterated | 19 Nov 2024 |
Citigroup Daniel Grosslight 41% 1-year accuracy 7 / 17 met price target | 11%downside $1.75 | Sell Maintained | 13 Nov 2024 |
Stifel Craig Jones 57% 1-year accuracy 4 / 7 met price target | 2%upside $2 | Hold Maintained | 12 Nov 2024 |
Financial journalist opinion
Based on 3 articles about AGL published over the past 30 days
Negative
Zacks Investment Research
1 week ago
New Strong Sell Stocks for December 13th
AGL, BKGFY and BERY have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2024.
Negative
Zacks Investment Research
2 weeks ago
New Strong Sell Stocks for December 4th
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024.
Negative
Zacks Investment Research
2 weeks ago
New Strong Sell Stocks for December 2nd
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024.
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for November 19th
AGL, AFLYY and BATRK have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024.
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for November 13th
AOS, AGL and ABG have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2024.
Neutral
Business Wire
1 month ago
agilon health Reports ACO REACH Model Results for 2023 Performance Year
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $150 million in gross savings (13% gross savings rate), including $37 million savings to the Medicare Trust Fund, during the 2023 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon's eight REACH ACOs operate under full risk, and in.
Neutral
Seeking Alpha
1 month ago
agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Michael Ha - Baird Thomas Keller - RBC Daniel Grosslight - Citi Operator Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call.
Negative
Seeking Alpha
1 month ago
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummeted 60.1% since my last article, driven by disappointing Q3 results and reduced guidance, despite revenue growth. Rising medical costs and expansion expenses have severely impacted profitability, with a significant increase in net loss and negative EBITDA.
Positive
Zacks Investment Research
1 month ago
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Negative
Zacks Investment Research
1 month ago
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates
Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago.
Charts implemented using Lightweight Charts™